A phase Ib study of oxaliplatin in combination with fluorouracil (5FU) and leucovorin (LV) in pediatric patients (pts) with advanced solid tumors

被引：0
|
作者：
Gore, L.
Kuttesch, J.
Hunger, S. P.
Herzog, C.
Narendaren, A.
Boklan, J.
Foreman, N. K.
Ivy, S. P.
Boucher, N.
Trippett, T. M.
机构：
[1] UCHSC Fitzsimons, Aurora, CO USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Univ Florida, Shands Canc Ctr, Gainesville, FL USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Univ Calgary, Alberta Childrens Hosp, Calgary, AB, Canada
[6] Phoenix Childrens Hosp, Phoenix, AZ USA
[7] NCI, Rockville, MD USA
[8] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9548
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Does the dose of leucovorin (LV) matter with 5-fluorouracil (5FU) in colorectal cancer (CRC)?
    Biagi, James Joseph
    Coakley, Nadia
    Earle, Craig
    Erlichman, Charles
    Fields, Anthony L. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [42] Phase I study of the combination of everolimus (RAD001) with 5FU/LV in patients with refractory solid malignancies
    Davies, J. M.
    McRee, A. J.
    Sanoff, H. K.
    Triglianos, T.
    Keller, K.
    Ivanova, A.
    Bernard, S. A.
    Goldberg, R. M.
    Dees, E. C.
    O'Neil, B. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [43] An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer
    Caponigro, F.
    Lacombe, D.
    Twelves, C.
    Bauer, J.
    Govaerts, A. -S.
    Marreaub, S.
    Milano, A.
    Anthoney, A.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 48 - 55
  • [44] Phase I trial to determine the safety and tolerability of GW572016 in combination with oxaliplatin (OX)/5-fluorouracil (5-FU)/leucovorin (LV) [FOL-FOX41 in patients with solid tumors.
    Lakhai, WS
    Beijnen, JH
    Den Boer, SS
    Westermann, AM
    Versola, M
    Koch, K
    Ho, P
    Pandite, L
    Richel, DJ
    Schellens, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 138S - 138S
  • [45] A phase Ib/II study of PXD101 alone and in combination with 5-fluorouracil in patients with advanced solid tumors
    Northfelt, D. W.
    Marschke, R. F., Jr.
    Bonnem, E.
    Ooi, C. E.
    Gerwien, R.
    Hawthorne, T.
    Clarke, A.
    Buhl-Jensen, P.
    Von Hoff, D.
    Grem, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] Phase I trial of BAY 43-9006 in combination with 5-fluorouracil (5-FU) and leucovorin (LCV) in patients with advanced refractory solid tumors
    Figer, A.
    Moscovici, M.
    Bulocinic, S.
    Radu, P.
    Atsmon, J.
    Shmuely, E.
    Laba, O.
    Gadish, D.
    Brendel, E.
    Schwartz, B.
    ANNALS OF ONCOLOGY, 2004, 15 : 87 - 88
  • [47] Weekly oxaliplatin (OXA), 5-fluorouracil (FU) and leucovorin (LV) as first line treatment for advanced colorectal cancer (CRC) - A phase II study.
    Tsavdaridis, D
    Athanasiadis, A
    Pissanidis, N
    Saleh, M
    Moshidis, A
    Chatzichristou, A
    Makrantonakis, N
    Kamentsidis, P
    Natsiopoulos, I
    Christakis, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 297S - 297S
  • [48] 5-fluorouracil (5FU)/leucovorin (LV) followed by irinotecan (CPT-11) versus CPT-11 followed by 5-FU/LV at relapse in patients with advanced colorectal carcinoma. Phase III randomized study
    Tsavaris, N.
    Kosmas, C.
    Skopelitis, E.
    Papadoniou, N.
    Polyzos, A.
    Zografos, G.
    Diamartis, N.
    Ntokou, A.
    Tsaousi, S.
    Sarantonis, I
    Adoniou, E.
    Gryniatsos, J.
    Felekouras, E.
    Papalambros, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 81 - 81
  • [49] Phase I-II study of gemcitabine (GEM) in combination with 24 hours continuous infusion (CI) of 5-fluorouracil (5-FU) and leucovorin (LV) in patients (pts) with advanced pancreatic carcinoma (APC).
    Lencioni, M
    Falcone, A
    Masi, G
    Fioretto, L
    Di Marsico, R
    Pfanner, E
    Fontana, E
    Galli, C
    Bonifazi, V
    Conte, PF
    ANNALS OF ONCOLOGY, 2000, 11 : 66 - 66
  • [50] Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer(ACC)
    Punt, CJA
    Keizer, HJ
    Douma, J
    Schüller, J
    Skovsgaard, T
    ten Napel, CHH
    Lochs, H
    Muller, EW
    Russell, L
    Wagener, DJT
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S68 - S68
12345